SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-025864
Filing Date
2023-07-28
Accepted
2023-07-28 16:05:37
Documents
14
Period of Report
2023-07-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44567
2 ex10-1.htm EX-10.1 13149
  Complete submission text file 0001493152-23-025864.txt   279580

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE biaf-20230726.xsd EX-101.SCH 3785
4 XBRL DEFINITION FILE biaf-20230726_def.xml EX-101.DEF 26626
5 XBRL LABEL FILE biaf-20230726_lab.xml EX-101.LAB 36673
6 XBRL PRESENTATION FILE biaf-20230726_pre.xml EX-101.PRE 25250
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5312
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

IRS No.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 231123025
SIC: 8731 Services-Commercial Physical & Biological Research